Location: Miami, FL
CIK: 0001937964 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $631M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| INSM | INSMED INC | 732,212 | $105M | 16.7% | $72.29 | +69.5% | COM PAR $.01 | 457669307 |
| ARGX | ARGENX SE | 78,311 | $57.76M | 9.2% | $527.57 | — | SPONSORED ADR | 04016X101 |
| INSM | INSMED INC | 400,000 | $57.6M | 9.1% | $72.29 | +69.5% | Call | 457669307 |
| SLNO | SOLENO THERAPEUTICS INC | 672,176 | $45.44M | 7.2% | $55.51 | +33.6% | COM | 834203309 |
| — | VERONA PHARMA PLC | 379,004 | $40.44M | 6.4% | $67.66 | — | SPONSORED ADS | 925050106 |
| QURE | UNIQURE NV | 658,839 | $38.46M | 6.1% | $18.16 | 0.0% | SHS | N90064101 |
| — | MERUS N V | 296,750 | $27.94M | 4.4% | $42.88 | — | COM | N5749R100 |
| UGL | PROSHARES TR II | 537,372 | $24.75M | 3.9% | $46.06 | — | ULTRA GOLD | 74347W601 |
| LLY | ELI LILLY & CO | 28,700 | $21.9M | 3.5% | $826.69 | -10.2% | COM | 532457108 |
| VRTX | VERTEX PHARMACEUTICALS INC | 55,100 | $21.58M | 3.4% | $421.35 | -0.8% | COM | 92532F100 |
| ABVX | ABIVAX SA | 225,453 | $19.14M | 3.0% | $84.90 | — | SPONSORED ADS | 00370M103 |
| TRVI | TREVI THERAPEUTICS INC | 1,999,702 | $18.3M | 2.9% | $6.66 | +12.6% | COM | 89532M101 |
| BSX | BOSTON SCIENTIFIC CORP | 183,200 | $17.89M | 2.8% | $101.20 | +2.3% | COM | 101137107 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 34,570 | $15.76M | 2.5% | $280.16 | +45.3% | COM | 02043Q107 |
| DGX | QUEST DIAGNOSTICS INC | 81,717 | $15.57M | 2.5% | $165.04 | +7.0% | COM | 74834L100 |
| AZN | ASTRAZENECA PLC | 190,752 | $14.63M | 2.3% | $69.76 | — | SPONSORED ADR | 046353108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 628,367 | $8.948M | 1.4% | $10.54 | +9.2% | COM NEW | 30233G209 |
| REGN | REGENERON PHARMACEUTICALS | 10,671 | $6M | 1.0% | $556.12 | +1.5% | COM | 75886F107 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 194,838 | $5.541M | 0.9% | $23.17 | +3.5% | ORDINARY SHARES | N62509109 |
| RVMD | REVOLUTION MEDICINES INC | 104,190 | $4.866M | 0.8% | $48.13 | -18.7% | COM | 76155X100 |
| RNAM | AVIDITY BIOSCIENCES INC | 110,100 | $4.797M | 0.8% | $37.09 | +9.0% | COM | 05370A108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 150,000 | $4.512M | 0.7% | $33.92 | -11.6% | Call | 90400D108 |
| DNTH | DIANTHUS THERAPEUTICS INC | 108,723 | $4.278M | 0.7% | $25.56 | 0.0% | COM | 252828108 |
| IONS | IONIS PHARMACEUTICALS INC | 60,176 | $3.937M | 0.6% | $48.82 | 0.0% | COM | 462222100 |
| VKTX | VIKING THERAPEUTICS INC | 146,179 | $3.842M | 0.6% | $28.75 | +3.8% | COM | 92686J106 |
| SRRK | SCHOLAR ROCK HLDG CORP | 96,285 | $3.586M | 0.6% | $38.47 | -9.1% | COM | 80706P103 |
| ABBV | ABBVIE INC | 14,500 | $3.357M | 0.5% | $182.67 | +10.6% | COM | 00287Y109 |
| NKTR | NEKTAR THERAPEUTICS | 57,999 | $3.3M | 0.5% | $33.10 | 0.0% | COM NEW | 640268306 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 133,291 | $3.232M | 0.5% | $24.25 | — | SPONSORED ADS | 152309100 |
| ASND | ASCENDIS PHARMA A/S | 12,240 | $2.433M | 0.4% | $159.57 | — | SPONSORED ADR | 04351P101 |
| MLYS | MINERALYS THERAPEUTICS INC | 56,600 | $2.146M | 0.3% | $16.45 | +31.5% | COM | 603170101 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 5,000 | $2.096M | 0.3% | $342.70 | -1.9% | COM | 91307C102 |
| TGTX | TG THERAPEUTICS INC | 54,515 | $1.969M | 0.3% | $28.70 | +14.8% | COM | 88322Q108 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 64,502 | $1.94M | 0.3% | $33.92 | -11.6% | COM | 90400D108 |
| RAPP | RAPPORT THERAPEUTICS INC | 64,608 | $1.919M | 0.3% | $17.84 | 0.0% | COM | 75383L102 |
| OCUL | OCULAR THERAPEUTIX INC | 141,061 | $1.649M | 0.3% | $11.96 | 0.0% | COM | 67576A100 |
| XENE | XENON PHARMACEUTICALS INC | 40,000 | $1.606M | 0.3% | $46.00 | -23.4% | COM | 98420N105 |
| IREN | IREN LIMITED | 33,200 | $1.558M | 0.2% | $24.29 | 0.0% | ORDINARY SHARES | Q4982L109 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 22,951 | $1.525M | 0.2% | $36.55 | +55.5% | COM | 74366E102 |
| BTSG | BRIGHTSPRING HEALTH SVCS INC | 41,600 | $1.23M | 0.2% | $23.24 | 0.0% | COM | 10950A106 |
| BHVN | BIOHAVEN LTD | 80,000 | $1.201M | 0.2% | $17.82 | -18.3% | COM | G1110E107 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 29,200 | $1.134M | 0.2% | $25.46 | +27.6% | ORD SHS CL A | G52694109 |
| BBIO | BRIDGEBIO PHARMA INC | 20,400 | $1.06M | 0.2% | $48.77 | 0.0% | COM | 10806X102 |
| MREO | MEREO BIOPHARMA GROUP PLC | 475,361 | $979K | 0.2% | $3.23 | — | SPON ADS | 589492107 |
| SRPT | SAREPTA THERAPEUTICS INC | 44,900 | $865K | 0.1% | $17.83 | 0.0% | COM | 803607100 |
| TVTX | TRAVERE THERAPEUTICS INC | 30,900 | $739K | 0.1% | $20.30 | -7.4% | COM | 89422G107 |
| MRNA | MODERNA INC | 23,800 | $615K | 0.1% | $27.90 | 0.0% | COM | 60770K107 |
| KALV | KALVISTA PHARMACEUTICALS INC | 41,555 | $506K | 0.1% | $13.82 | 0.0% | COM | 483497103 |
| ATYR | ATYR PHARMA INC | 600,000 | $433K | 0.1% | $4.53 | 0.0% | Call | 002120202 |
| ATYR | ATYR PHARMA INC | 372,276 | $269K | 0.0% | $4.53 | 0.0% | COM NEW | 002120202 |
| ALEC | ALECTOR INC | 71,029 | $210K | 0.0% | $2.20 | 0.0% | COM | 014442107 |